Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$342M |
| 2 |
NVIDIA
NVDA
|
+$330M |
| 3 |
Capital One
COF
|
+$288M |
| 4 |
Johnson & Johnson
JNJ
|
+$169M |
| 5 |
AMRZ
Amrize Ltd
AMRZ
|
+$164M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.01B |
| 2 |
Microsoft
MSFT
|
+$999M |
| 3 |
DFS
Discover Financial Services
DFS
|
+$296M |
| 4 |
Eli Lilly
LLY
|
+$215M |
| 5 |
Amazon
AMZN
|
+$185M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.29% |
| 2 | Financials | 13.54% |
| 3 | Consumer Discretionary | 9.85% |
| 4 | Healthcare | 9.21% |
| 5 | Communication Services | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MBCN
3001
DELISTED
Middlefield Banc Corp
MBCN
| $20.1K | ﹤0.01% |
669
+69
| +12% | +$1.92K |
|
3002
Palladyne AI
PDYN
$291M
| $20.1K | ﹤0.01% |
+2,324
| New | +$16.5K |
|
3003
Mayville Engineering Co
MEC
$633M
| $20.1K | ﹤0.01% |
1,260
| – | – |
|
|
ATXS
3004
DELISTED
Astria Therapeutics
ATXS
| $20.1K | ﹤0.01% |
3,744
-27,674
| -88% | -$134K |
|
3005
Zumiez
ZUMZ
$332M
| $19.9K | ﹤0.01% |
1,503
| – | – |
|
|
HIMX
3006
Himax Technologies
HIMX
$2.4B
| $19.8K | ﹤0.01% |
2,214
| – | – |
|
3007
CuriosityStream
CURI
$159M
| $19.7K | ﹤0.01% |
+3,505
| New | +$16.1K |
|
3008
Radiant Logistics
RLGT
$395M
| $19.7K | ﹤0.01% |
3,235
| – | – |
|
3009
Erasca
ERAS
$6.34B
| $19.6K | ﹤0.01% |
15,428
-171,397
| -92% | -$229K |
|
3010
MaxCyte
MXCT
$119M
| $19.5K | ﹤0.01% |
8,963
-16,207
| -64% | -$39.2K |
|
3011
Pure Cycle
PCYO
$257M
| $19.5K | ﹤0.01% |
1,818
-262
| -13% | -$2.72K |
|
3012
Cardiff Oncology
CRDF
$74.7M
| $19.5K | ﹤0.01% |
6,185
+633
| +11% | +$1.93K |
|
3013
Forum Energy Technologies
FET
$846M
| $19.4K | ﹤0.01% |
998
| – | – |
|
|
CIO
3014
DELISTED
City Office REIT
CIO
| $19.4K | ﹤0.01% |
3,629
+358
| +11% | +$1.79K |
|
|
INZY
3015
DELISTED
Inozyme Pharma
INZY
| $19.3K | ﹤0.01% |
4,813
| – | – |
|
|
FVR
3016
FrontView REIT
FVR
$456M
| $19.2K | ﹤0.01% |
1,604
+380
| +31% | +$4.49K |
|
3017
LCNB Corp
LCNB
$285M
| $19.2K | ﹤0.01% |
1,324
+337
| +34% | +$4.89K |
|
3018
Verastem
VSTM
$519M
| $19.2K | ﹤0.01% |
4,617
+401
| +10% | +$2.51K |
|
|
ESPR
3019
DELISTED
Esperion Therapeutics
ESPR
| $19.2K | ﹤0.01% |
19,464
+1,923
| +11% | +$1.93K |
|
3020
Monte Rosa Therapeutics
GLUE
$1.33B
| $19.1K | ﹤0.01% |
4,245
+648
| +18% | +$2.89K |
|
3021
3D Systems Corp
DDD
$588M
| $19.1K | ﹤0.01% |
12,426
+1,389
| +13% | +$2.51K |
|
3022
iHeartMedia
IHRT
$574M
| $19.1K | ﹤0.01% |
10,846
+1,958
| +22% | +$2.61K |
|
3023
Sight Sciences
SGHT
$391M
| $19K | ﹤0.01% |
4,605
+720
| +19% | +$2.4K |
|
3024
AMC Global Media
AMCX
$490M
| $19K | ﹤0.01% |
3,031
| – | – |
|
3025
Biglari Holdings Class B
BH
$1.22B
| $19K | ﹤0.01% |
65
| – | – |
|
Similar funds
Legal & General Group's Q2 2025 Portfolio in Review
As of Q2 2025, Legal & General Group held 3,602 positions worth $403B, up 9.7% from $367B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Legal & General Group's Q2 2025 filing shows 227 new, 1,896 increased, 1,081 reduced and 186 closed positions. Its largest new stake was Amrize Ltd: 3,253,080 shares worth $162M. The largest sale was Apple, an estimated $1.01B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Financials and Consumer Discretionary.
- Legal & General Group's largest Q2 2025 buy was Amrize Ltd: 3,253,080 shares worth $162M.
- Legal & General Group added most to Tesla in Q2 2025, an estimated $342M increase.
- Legal & General Group's biggest Q2 2025 reduction was Apple, cutting an estimated $1.01B.
- Legal & General Group fully exited Discover Financial Services in Q2 2025, selling an estimated $296M.
- Legal & General Group's ten largest holdings make up 32% of its $403B portfolio in Q2 2025.
- Legal & General Group opened 227 new positions and closed 186 in Q2 2025.
- Legal & General Group's portfolio value rose 9.7% quarter-over-quarter to $403B.
Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.